The stock is Cybin Inc (NYSEAMERICAN: CYBN)

It is currently up +0.20 (58.18%) in the past 5 days.

Why are we interested in it?

- Steve Cohen’s hedge fund Point72 purchases almost 19M shares.

The investment in Cybin by the hedge fund has been welcomed as a validation for the psychedelics sector as a whole, with retail investors largely dominating the space to date.

All in all a very interesting company.

‍

Disclaimer: This content is made for entertainment purposes only. This is not financial advice